BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37805393)

  • 1. [Plurihormonal PIT1-lineage pituitary neuroendocrine tumors: a clinicopathological study].
    Duan ZJ; Feng J; Zhao HQ; Wang HD; Gui QP; Zhang XF; Ma Z; Hu ZJ; Xiang L; Qi XL
    Zhonghua Bing Li Xue Za Zhi; 2023 Oct; 52(10):1017-1024. PubMed ID: 37805393
    [No Abstract]   [Full Text] [Related]  

  • 2. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.
    Asa SL; Mete O; Riddle ND; Perry A
    Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the 2022 WHO Classification of Pituitary Tumors.
    Asa SL; Mete O; Perry A; Osamura RY
    Endocr Pathol; 2022 Mar; 33(1):6-26. PubMed ID: 35291028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plurihormonal Pituitary Neuroendocrine Tumours - A Single Centre Experience.
    Mihajlović M; Pekić S; Doknić M; Stojanović M; Rašić D; Miljić D; Petakov M; Manojlović Gačić E
    Int J Surg Pathol; 2024 May; 32(3):470-477. PubMed ID: 37438981
    [No Abstract]   [Full Text] [Related]  

  • 5. [New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].
    Xie J; Wu ZB
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3723-3726. PubMed ID: 36517420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features.
    Dottermusch M; Ryba A; Ricklefs FL; Flitsch J; Schmid S; Glatzel M; Saeger W; Neumann JE; Schüller U
    Acta Neuropathol; 2024 Jan; 147(1):16. PubMed ID: 38228887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors.
    Silva-Ortega S; García-Martinez A; Niveiro de Jaime M; Torregrosa ME; Abarca J; Monjas I; Picó Alfonso A; Aranda López I
    Hum Pathol; 2021 Apr; 110():20-30. PubMed ID: 33321163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical presentation of PIT1 positive pituitary neuroendocrine tumor immunonegative for growth hormone, prolactin, and thyroid stimulating hormone with analysis of clinical and immunostaining dissociation.
    Hong S; Shinya Y; Trejo-Lopez JA; Gruber LM; Erickson D; Bendok BR; Chaichana KL; Atkinson JL; Marino MJ; Donaldson AM; Stokken JK; Westphal SA; Chang AY; Samson SL; Choby GW; Van Gompel JJ
    Clin Neurol Neurosurg; 2024 Jan; 236():108075. PubMed ID: 38056042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular cells in pituitary neuroendocrine tumors.
    Delfin L; Mete O; Asa SL
    Hum Pathol; 2021 Aug; 114():1-8. PubMed ID: 33991528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset.
    Luo M; Tang R; Wang H
    J Neurooncol; 2023 Jul; 163(3):663-674. PubMed ID: 37418134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of an Immature PIT1-Lineage Pituitary Neuroendocrine Tumor of the Nasopharynx.
    Peters J; Gryn O; Gerka-Stuyt J
    Cureus; 2023 Sep; 15(9):e44985. PubMed ID: 37701167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plurihormonal pituitary macroadenoma:  a case report.
    Allehaibi E; AlMalki MH; Brema I
    J Med Case Rep; 2021 Jul; 15(1):407. PubMed ID: 34321093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism.
    Asa SL; Ezzat S
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34067494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digital image analysis allows objective stratification of patients with silent PIT1-lineage pituitary neuroendocrine tumors.
    Zhao J; Ji C; Cheng H; Ye Z; Yao B; Shen M; Shou X; Zhou X; Ye H; Zhang Z; Chen H; Wang Y; He F; Zhao Y; Gong W; Zhang Q; Qiao N
    J Pathol Clin Res; 2023 Nov; 9(6):488-497. PubMed ID: 37661840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plurihormonal pituitary adenomas: immunostaining of all pituitary hormones is mandatory for correct classification.
    Ho DM; Hsu CY; Ting LT; Chiang H
    Histopathology; 2001 Sep; 39(3):310-9. PubMed ID: 11532042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acidophil stem cell pituitary neuroendocrine tumors/adenoma: a clinicopathological analysis of five cases].
    Lou L; Du SX; Fu YT; Shao QQ; Guo WL; Zong YP; Qin MM; Tian XX; Li YH
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):446-451. PubMed ID: 38678324
    [No Abstract]   [Full Text] [Related]  

  • 17. How to Classify the Pituitary Neuroendocrine Tumors (PitNET)s in 2020.
    Trouillas J; Jaffrain-Rea ML; Vasiljevic A; Raverot G; Roncaroli F; Villa C
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32098443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory Pit1 plurihormonal tumours and thyrotroph adenomas.
    Nf L; Ai M
    Pituitary; 2023 Apr; 26(2):182-186. PubMed ID: 37117845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observation of Clinicopathologic Features of Pituitary Adenoma With Neuronal Differentiation.
    Zheng L; Yan X; Hu C; Zhang P; Chen Y; Zheng Q; Hu L; Wang M; Li G; Wu P; Jiang C; Tian J; Zhang S; Wang X
    Front Endocrinol (Lausanne); 2022; 13():848762. PubMed ID: 35370935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
    Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
    Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.